The effect of valerian and lavender essential oil on coronary heart disease

Not Applicable

Recruiting

• Conditions: Coronary artery disease.; Atherosclerotic heart disease of native coronary artery; I25.1

• Registration Number: IRCT20210516051316N1
• Lead Sponsor: Qazvin University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 1 November 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

No previous history of nitrate use
no history of allergies
no use of painkillers 6 hours before the intervention
no headache before the intervention
no use of perfume or cologne before or during the intervention
No history of drug addiction according to the patient
no olfactory disorder according to the patient

Exclusion Criteria

Withdrawal from the study
having a headache before the infusion of nitroglycerin
decreased level of consciousness during the study
allergies caused by the essential oils of valerian and lavender or herbal essences during the study

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood pressure. Timepoint: 30 minutes (before the intervention and 15, 30). Method of measurement: manometer.;Drug use following the inhalation of fragrance and its effect on headache The need for narcotics changes based on the visual pain scale. Timepoint: 30 minutes (before the intervention and 15, 30). Method of measurement: Visual Analogue Scale.;Heart rate. Timepoint: 30 minutes (before the intervention and 15, 30). Method of measurement: Heart rate monitoring device.;Temperature. Timepoint: 30 minutes (before the intervention and 15, 30). Method of measurement: Mercury thermometer.;Respiratory Rate. Timepoint: 30 minutes (before the intervention and 15, 30). Method of measurement: Count the number of breaths per minute based on chest movements while breathing.;Percentage of blood oxygen saturation. Timepoint: 30 minutes (before the intervention and 15, 30). Method of measurement: pulse oximetry.

Secondary Outcome Measures

Name	Time	Method
Pain. Timepoint: 30 minutes (before the intervention and 15, 30). Method of measurement: Visual Analogue Scale (VAS ).